Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22278
Title: Reply.
Austin Authors: Sinclair, Marie ;Chapman, Brooke ;Hoermann, Rudolf;Angus, Peter W ;Testro, Adam G ;Scodellaro, Thomas ;Gow, Paul J 
Affiliation: Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Feb-2020
metadata.dc.date: 2020-01-08
Publication information: Liver Transplantation 2019; 26(2): 309-310
Abstract: Thank you for your interest in our recent publication 'Handgrip strength adds more prognostic value to the Model for End-Stage Liver Disease score than imaging-based measures of muscle mass in men with cirrhosis' (1). We agree that the most widely recognised definition of sarcopenia, proposed by the European Working Group on Sarcopenia in Older People (EWGSOP) incorporates both low muscle strength and low muscle mass (2). Hence the letter authors are critical of our use of a sarcopenia 'diagnosis' based on individual tests results only (handgrip strength (HGS), dual energy X-ray absorptiometry (DEXA) lean mass, and single slice computed tomography (CT) scan at the fourth lumbar vertebra). Whilst acknowledging that our sarcopenia diagnosis does not meet the criteria proposed by EWGSOP, it is important to note the majority of literature relating to cirrhotic patients, report only CT-based measures of muscle mass (3-5).
URI: http://ahro.austin.org.au/austinjspui/handle/1/22278
DOI: 10.1002/lt.25700
ORCID: 0000-0002-1326-4270
PubMed URL: 31833637
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on May 13, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.